Tyrosine kinase inhibitors as an alternative treatment in canine mast cell tumor

The current gold standard treatment for canine mast cell tumors (MCT) uses vinblastine sulfate (VBL) as chemotherapy, although tyrosine kinase inhibitors (TKI) have recently been shown to be worthy candidates for treatment. This systematic review aimed to analyze the overall survival (OS), progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Yasmin Nascimento Bernardes, Soldi, Luiz Ricardo, da Silva, Paulo Henrique Rosa, Mesquita, Caio Melo, Paranhos, Luiz Renato, dos Santos, Thaísa Reis, Silva, Marcelo José Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285312/
https://www.ncbi.nlm.nih.gov/pubmed/37360406
http://dx.doi.org/10.3389/fvets.2023.1188795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285312/
https://www.ncbi.nlm.nih.gov/pubmed/37360406
http://dx.doi.org/10.3389/fvets.2023.1188795

Ejemplares similares